Health minister says stiffer rules could prevent over prescribing to U.S. patients | 24CA News
The federal well being minister says laws governing medical observe could must be strengthened in every province to forestall “incompetence” by docs who may write hundreds of prescriptions for medicine that go to sufferers exterior of Canada.
Jean-Yves Duclos mentioned that on the very least, regulatory faculties could have to raised implement present laws so medicines such because the diabetes drug Ozempic — additionally used off-label to shed pounds — can be found to Canadians who want them.
Concern over potential drug shortages arose after a Texas-based physician licensed in Nova Scotia wrote 17,000 prescriptions for Ozempic over three months, however for individuals dwelling within the United States.
Regulatory faculties and provinces ought to guard towards an analogous challenge arising if entry to different medicines such because the abortion drug mifepristone is restricted in some elements of the United States, Duclos mentioned.
“I will be raising this issue with my counterparts, health ministers, because this is one example of possibly future examples,” Duclos mentioned Thursday in an interview.
“It’s incompetence,” he mentioned, including that’s how the College of Physicians and Surgeons additionally described the actions of the Texas physician.
“The number is completely out of proportion to the reality of what a good physician would need to do according to medical guidelines.”
Each province and territory has its personal laws for health-care suppliers and people laws must be amended by particular person governments.
The Nova Scotia faculty issued an interim suspension of the Texas physician’s licence final week primarily based on provisions within the Nova Scotia Medical Act, which says such a penalty may be levied the place there are possible grounds to consider sufferers are susceptible to hurt or damage.
The faculty mentioned an investigation is constant.
The medicine have been allotted by two pharmacies in British Columbia and shipped to the United States.
B.C. Health Minister Adrian Dix mentioned that within the coming weeks, his province will amend laws of the College of Pharmacists of British Columbia to cease exports to the United States of any drug to keep away from a possible scarcity.
He mentioned the Ozempic case got here to mild when the province seen a excessive quantity of prescriptions crammed by two pharmacies by a community referred to as PharmaNet, which tracks each prescription crammed in a neighborhood pharmacy.
“I was already concerned when we announced the extension of Pharmacare coverage for Ozempic at the beginning of January. We focused on it,” Dix mentioned.
“I’m satisfied we’re taking action and we’ll deal with B.C. I’m encouraging the federal government to get involved so we address this issue for Canada.”
Duclos mentioned Health Canada would contemplate limiting the majority export of any drug by the Food and Drugs Act to protect provides for Canada.
“The key word here is bulk — that planes and trucks of the drug that is in shortage will be leaving Canada to go elsewhere.”
However, Dix mentioned hundreds of particular person doses are additionally problematic and demand a nationwide response, particularly if U.S. drug costs far exceed these in Canada and spur Americans to order medicine from Canadian pharmacies.
Better knowledge sharing between provinces and territories may permit faster motion towards docs who prescribe huge quantities of a specific drug, Duclos mentioned.
“It’s challenging for individual provinces and territories and individual colleges of all sorts to do that work in silos. In this case, it was a physician (licensed) in Nova Scotia, but next time it may well be someone in Ontario or Manitoba.”
Dr. Akshay Jain, an endocrinologist who specializes within the administration of diabetes and weight problems in Surrey, B.C., mentioned obese sufferers ought to have entry to Ozempic as a result of they too must deal with a power illness.
“About 36 per cent of Canadians live with obesity and an additional 24 per cent are overweight. So that’s over 60 per cent of Canadian adults, whereas only 11 per cent of adults have diabetes,” mentioned Jain.
Jain mentioned a month’s provide of the drug prices about $200 in Canada, in comparison with $1,100 within the United States.
Most provinces don’t cowl medicines for weight problems, he mentioned, and left untreated that may result in issues together with diabetes, hypertension and the necessity for hip and knee replacements as a result of extra physique weight.
That prices the health-care system extra money in the long run, he mentioned.
Ozempic is a brand-name diabetes remedy manufactured by Novo Nordisk, however the medical ingredient in it’s referred to as semaglutide.
Semaglutide works by mimicking a hormone referred to as glucagon-like peptide-1 (GLP-1), which stimulates the discharge of insulin and helps to scale back blood sugar spikes.
It additionally slows down the emptying of the abdomen and motion of meals by the intestine, making an individual really feel full longer and stabilizing blood sugar ranges.
But that’s not all that semaglutide has been proven to do — it’s additionally efficient at regulating food regimen by concentrating on areas of the mind that make an individual really feel extra full.
Novo Nordisk really manufactures two medicine the place semaglutide is the one medical ingredient: Ozempic for sort 2 diabetes, and Wegovy for weight problems.
Wegovy was accredited by Health Canada in 2021 however continues to be not obtainable in Canada.
A spokeswoman with Novo Nordisk mentioned it’s working to make Wegovy commercially obtainable however couldn’t say when that might occur.
Both Wegovy and Ozempic are administered by weekly injections. The solely distinction between the 2 is that Wegovy may be injected at the next dosage.
Another very comparable drug — liraglutide — works virtually an identical to Ozempic and Wegovy however however concerned every day injections.
For diabetes it’s bought beneath the title Victoza however for weight reduction, it’s labeled as Saxenda and the injection pen places out a bigger dose.
Saxenda and Victoza are additionally manufactured by Novo Nordisk.
Canadian Press well being protection receives assist by a partnership with the Canadian Medical Association. CP is solely chargeable for this content material.
— With information from Karen Bartko, Global News
